These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8825897)

  • 1. Exclusion of close linkage between the synaptic vesicular monoamine transporter locus and schizophrenia spectrum disorders.
    Persico AM; Wang ZW; Black DW; Andreasen NC; Uhl GR; Crowe RR
    Am J Med Genet; 1995 Dec; 60(6):563-5. PubMed ID: 8825897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exclusion of close linkage of the dopamine transporter gene with schizophrenia spectrum disorders.
    Persico AM; Wang ZW; Black DW; Andreasen NC; Uhl GR; Crowe RR
    Am J Psychiatry; 1995 Jan; 152(1):134-6. PubMed ID: 7802105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exon/intron boundaries, novel polymorphisms, and association analysis with schizophrenia of the human synaptic vesicle monoamine transporter (SVMT) gene.
    Kunugi H; Ishida S; Akahane A; Nanko S
    Mol Psychiatry; 2001 Jul; 6(4):456-60. PubMed ID: 11443533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of membrane and vesicular monoamine transporters in the neurotoxic and hypothermic effects of 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH(2)-MPTP).
    Numis AL; Unger EL; Sheridan DL; Chisnell AC; Andrews AM
    Mol Pharmacol; 2004 Sep; 66(3):718-27. PubMed ID: 15322265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata.
    Staal RG; Sonsalla PK
    J Pharmacol Exp Ther; 2000 May; 293(2):336-42. PubMed ID: 10773000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient developmental expression of monoamine transporters in the rodent forebrain.
    Lebrand C; Cases O; Wehrlé R; Blakely RD; Edwards RH; Gaspar P
    J Comp Neurol; 1998 Nov; 401(4):506-24. PubMed ID: 9826275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium.
    Staal RG; Hogan KA; Liang CL; German DC; Sonsalla PK
    J Pharmacol Exp Ther; 2000 May; 293(2):329-35. PubMed ID: 10772999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons.
    Liang CL; Nelson O; Yazdani U; Pasbakhsh P; German DC
    J Comp Neurol; 2004 May; 473(1):97-106. PubMed ID: 15067721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase A affects trafficking of the vesicular monoamine transporters in PC12 cells.
    Yao J; Erickson JD; Hersh LB
    Traffic; 2004 Dec; 5(12):1006-16. PubMed ID: 15522101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vesicular monoamine transporter-2: immunogold localization in striatal axons and terminals.
    Nirenberg MJ; Chan J; Liu Y; Edwards RH; Pickel VM
    Synapse; 1997 Jun; 26(2):194-8. PubMed ID: 9131778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
    Kilbourn MR; Kuszpit K; Sherman P
    Synapse; 2000 Mar; 35(4):250-5. PubMed ID: 10657034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Region-specific targeting of dopamine D2-receptors and somatodendritic vesicular monoamine transporter 2 (VMAT2) within ventral tegmental area subdivisions.
    Pickel VM; Chan J; Nirenberg MJ
    Synapse; 2002 Aug; 45(2):113-24. PubMed ID: 12112404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association between polymorphic microsatellites of the VMAT2 gene and Parkinson's disease in Japan.
    Kariya S; Hirano M; Takahashi N; Furiya Y; Ueno S
    J Neurol Sci; 2005 May; 232(1-2):91-4. PubMed ID: 15850588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
    Suzuki M; Desmond TJ; Albin RL; Frey KA
    Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of vesicular monoamine transporter (VMAT) 1 and 2 in gastrointestinal endocrine tumours.
    Jakobsen AM; Andersson P; Saglik G; Andersson E; Kölby L; Erickson JD; Forssell-Aronsson E; Wängberg B; Ahlman H; Nilsson O
    J Pathol; 2001 Nov; 195(4):463-72. PubMed ID: 11745679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mice with very low expression of the vesicular monoamine transporter 2 gene survive into adulthood: potential mouse model for parkinsonism.
    Mooslehner KA; Chan PM; Xu W; Liu L; Smadja C; Humby T; Allen ND; Wilkinson LS; Emson PC
    Mol Cell Biol; 2001 Aug; 21(16):5321-31. PubMed ID: 11463816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies.
    Bottalico B; Larsson I; Brodszki J; Hernandez-Andrade E; Casslén B; Marsál K; Hansson SR
    Placenta; 2004 Jul; 25(6):518-29. PubMed ID: 15135235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation and regulation of psychostimulant-sensitive neurotransmitter transporters.
    Vaughan RA
    J Pharmacol Exp Ther; 2004 Jul; 310(1):1-7. PubMed ID: 15064332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The VMAT2 gene in mice and humans: amphetamine responses, locomotion, cardiac arrhythmias, aging, and vulnerability to dopaminergic toxins.
    Uhl GR; Li S; Takahashi N; Itokawa K; Lin Z; Hazama M; Sora I
    FASEB J; 2000 Dec; 14(15):2459-65. PubMed ID: 11099463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants.
    Brown JM; Hanson GR; Fleckenstein AE
    J Pharmacol Exp Ther; 2001 Mar; 296(3):762-7. PubMed ID: 11181904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.